Evaluation of Candidates for Lung Transplant—A Review of Patient-Specific Risk Factors

Author:

Leard Lorriana E.ORCID

Abstract

Abstract Purpose of review The purpose of this paper is to review the evaluation of patients who are potential candidates for a lung transplant. Attention is paid to patient-specific risk factors considered when determining if an individual is a candidate for a lung transplant. Recent findings Recent consensus statements and a review of the literature support the notion that patient-specific risk factors associated with adverse outcomes following lung transplant should be identified and used to determine whether an individual patient is a candidate for lung transplant. The rationale for considering these risk factors is discussed. Early referral is encouraged to enable individuals time to reduce risk when modifiable risk factors are identified. Summary Patient-specific risk factors for adverse post-lung transplant outcomes should be identified and modified, if possible, to reduce risk. Additional research is required to better understand which ones place the recipient at the greatest risk and to guide the calculation of acceptable risk. Interprofessional teams at each lung transplant center must consider the combination of patient-specific risk factors in a risk-benefit analysis to make the determination as to whether the candidate will be listed for a lung transplant. These determinations should be transparent, equitable, and communicated clearly.

Publisher

Springer Science and Business Media LLC

Reference40 articles.

1. Valapour M, Lehr CJ, Schladt DP, et al. OPTN/SRTR 2021 annual data report: lung. Am J Transplant. 2023;23(2 Suppl 1):S379–442. https://doi.org/10.1016/j.ajt.2023.02.009.

2. Holm AM, Mehra MR, Courtwright A, et al. Ethical considerations regarding heart and lung transplantation and mechanical circulatory support during the COVID-19 pandemic: an ISHLT COVID-19 Task Force statement. J Heart Lung Transplant. 2020;39(7):619–26. https://doi.org/10.1016/j.healun.2020.04.019.

3. •• Leard LE, Holm AM, Valapour M, et al. Consensus document for the selection of lung transplant candidates: an update from the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2021;40(11):1349–79. https://doi.org/10.1016/j.healun.2021.07.005. This paper is the most recent consensus document from the International Society for Heart and Lung Transplant highlighting disease-specific referral and listing recommendations as well as categorizing risk factors in the evaluation of lung transplant candidates.

4. King CS, White E, Aryal S, et al. Factors associated with listing for lung transplantation in IPF patients: an analysis of the pulmonary fibrosis foundation registry. Heliyon. 2023;9(8):e18618. Published 2023 Aug 5. https://doi.org/10.1016/j.heliyon.2023.e18618

5. Ramos KJ, Smith PJ, McKone EF, et al. Lung transplant referral for individuals with cystic fibrosis: Cystic Fibrosis Foundation consensus guidelines. J Cyst Fibros. 2019;18(3):321-333. Doi:10.1016/j.jcf.2019.03.002

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3